References

Arita S, Arita N, Hikasa Y. Therapeutic effect of low-dose imatinib on pulmonary arterial hypertension in dogs. Can Vet J. 2013; 54:(3)

Bach JF, Rozanski EA, MacGregor J Retrospective evaluation of sildenafil citrate as a therapy for pulmonary hypertension in dogs. J Vet Intern Med. 2006; 20:(5)1132-1135 https://doi.org/10.1892/0891-6640(2006)20[1132:reosca]2.0.co;2

Baron Toaldo M, Poser H, Menciotti G Utility of tissue doppler imaging in the echocardiographic evaluation of left and right ventricular function in dogs with myxomatous mitral valve disease with or without pulmonary hypertension. J Vet Intern Med. 2016; 30:(3)697-705 https://doi.org/10.1111/jvim.13940

Brewer FC, Sydney Moïse N, Kornreich BG Use of computed tomography and silicon endocasts to identify pulmonary veins with echocardiography. J Vet Cardiol. 2012; 14:(1)293-300 https://doi.org/10.1016/j.jvc.2012.02.004

Brown AJ, Davison E, Sleeper MM. Clinical efficacy of sildenafil in treatment of pulmonary arterial hypertension in dogs. J Vet Intern Med. 2010; 24:(4)850-854 https://doi.org/10.1111/j.1939-1676.2010.0517.x

Campbell FE. Cardiac effects of pulmonary disease. Vet Clin North Amer Small Anim Pract. 2007; 37:(5)949-962 https://doi.org/10.1016/j.cvsm.2007.05.006

Ettinger SJ, Feldman EC, Cote E. Textbook of veterinary internal medicine, 8th edn. St. Louis (MI): Elsevier Health Sciences; 2017

Goggs R, Chan DL, Benigni L Comparison of computed tomography pulmonary angiography and point-of-care tests for pulmonary thromboembolism diagnosis in dogs. J Small Anim Pract. 2014; 55:(4)190-197 https://doi.org/10.1111/jsap.12185

Hoeper MM, Bogaard HJ, Condliffe R Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013; 62:(25)D42-D50 https://doi.org/10.1016/j.jacc.2013.10.032

Jaffey JA, Leach SB, Kong LR Clinical efficacy of tadalafil compared to sildenafil in treatment of moderate to severe canine pulmonary hypertension: a pilot study. J Vet Cardiol. 2019; 24:7-19 https://doi.org/10.1016/j.jvc.2019.05.001

Johnson L, Boon JA, Orton EC. Clinical characteristics of 53 dogs with Doppler-derived evidence of pulmonary hypertension: 1992–1996. J Vet Intern Med. 1999; 13:(5)440-447 https://doi.org/10.1892/0891-6640(1999)013<0440:ccodwd>2.3.co;2

Kellihan HB, MacKie BA, Stepien RL. NT-proBNP, NT-proANP and cTnI concentrations in dogs with pre-capillary pulmonary hypertension. J Vet Cardiol. 2011; 13:(3)171-182 https://doi.org/10.1016/j.jvc.2011.04.003

Kellihan HB, Stepien RL. Pulmonary hypertension in dogs: diagnosis and therapy. Vet Clin Small Anim Pract. 2010; 40:(4)623-641 https://doi.org/10.1016/j.cvsm.2010.03.011

Kellihan HB, Waller KR, Pinkos A Acute resolution of pulmonary alveolar infiltrates in 10 dogs with pulmonary hypertension treated with sildenafil citrate: 2005–2014. J Vet Cardiol. 2015; 17:(3)182-191 https://doi.org/10.1016/j.jvc.2015.04.002

Kellum HB, Stepien RL. Sildenafil citrate therapy in 22 dogs with pulmonary hypertension. J Vet Intern Med. 2007; 21:(6)1258-1264 https://doi.org/10.1892/07-006.1

Kittleson MD, Kienle RD. Small animal cardiovascular medicine.St. Louis (MI): Mosby; 1998

Klein BG. Cunningham's textbook of veterinary physiology.St. Louis (MI): Saunders Elsevier; 2007

Kyranis SJ, Latona J, Platts D Improving the echocardiographic assessment of pulmonary pressure using the tricuspid regurgitant signal—the ‘chin’ vs the ‘beard’. Echocardiography. 2018; 35:(8)1085-1096 https://doi.org/10.1111/echo.13893

Lisciandro GR, Lagutchik MS, Mann KA Evaluation of a thoracic focused assessment with sonography for trauma (TFAST) protocol to detect pneumothorax and concurrent thoracic injury in 145 traumatized dogs. J Vet Emerg Crit Care. 2008; 18:(3)258-269 https://doi.org/10.1111/j.1476-4431.2008.00312.x

Masuyama T, Kodama K, Kitabatake A Continuous-wave Doppler echocardiographic detection of pulmonary regurgitation and its application to noninvasive estimation of pulmonary artery pressure. Circulation. 1986; 74:(3)484-492 https://doi.org/10.1161/01.CIR.74.3.484

Moller JH, Hoffman JI. Pediatric cardiovascular medicine.Philadelphia (PA): John Wiley and Sons; 2012

Ohad DG, Lenchner I, Bdolah-Abram T A loud right-apical systolic murmur is associated with the diagnosis of secondary pulmonary arterial hypertension: retrospective analysis of data from 201 consecutive client-owned dogs (2006–2007). Vet J. 2013; 198:(3)690-695 https://doi.org/10.1016/j.tvjl.2013.09.067

Pariaut R, Saelinger C, Strickland KN Tricuspid annular plane systolic excursion (TAPSE) in dogs: reference values and impact of pulmonary hypertension. J Vet Intern Med. 2012; 26:(5)1148-1154 https://doi.org/10.1111/j.1939-1676.2012.00981.x

Prosek R, Sisson DD, Oyama MA, Biondo AW, Solter PF. Plasma endothelin-1 immunoreactivity in normal dogs and dogs with acquired heart disease. J Vet Intern Med. 2004; 18:(6)840-844 https://doi.org/10.1892/0891-6640(2004)18<840:peiind>2.0.co;2

Pyle RL, Abbott J, MacLean H. Pulmonary hypertension and cardiovascular sequelae in 54 dogs. Intern J Appl Res Vet Med. 2004; 2:(2)99-109

Reinero C. Interstitial lung diseases in dogs and cats part I: the idiopathic interstitial pneumonias. Vet J. 2019; 243:48-54 https://doi.org/10.1016/j.tvjl.2013.09.067

Reinero CR, Jutkowitz LA, Nelson N Clinical features of canine pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis. J Vet Intern Med. 2019; 33:(1)114-123 https://doi.org/10.1111/jvim.15351

Reinero C, Visser LC, Kellihan HB ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs. J Vet Intern Med. 2020; 34:(2)549-573 https://doi.org/10.1111/jvim.15725

Rozanski E. Canine chronic bronchitis. Vet Clin Small Anim Pract. 2014; 44:(1)107-116 https://doi.org/10.1016/j.cvsm.2013.09.005

Schober KE, Baade H. Doppler echocardiographic prediction of pulmonary hypertension in West Highland white terriers with chronic pulmonary disease. J Vet Intern Med. 2006; 20:(4)912-920 https://doi.org/10.1892/0891-6640(2006)20[912:depoph]2.0.co;2

Serres F, Nicolle AP, Tissier R Efficacy of oral tadalafil, a new long-acting phosphodiesterase-5 inhibitor, for the short-term treatment of pulmonary arterial hypertension in a dog. J Vet Med Series A. 2006; 53:(3)129-133 https://doi.org/10.1111/j.1439-0442.2006.00800.x

Serres F, Chetboul V, Gouni V Diagnostic value of echo-Doppler and tissue Doppler imaging in dogs with pulmonary arterial hypertension. J Vet Intern Med. 2007; 21:(6)1280-1289 https://doi.org/10.1892/07-064.1

Simonneau G, Montani D, Celermajer DS Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019; 53:(1) https://doi.org/10.1183/13993003.01913-2018

Souza-Silva AR, Dias-Junior CA, Uzuelli JA Hemodynamic effects of combined sildenafil and L-arginine during acute pulmonary embolism-induced pulmonary hypertension. Eur J Pharmacol. 2005; 524:126-131 https://doi.org/10.1016/j.ejphar.2005.09.022

Sutherland-Smith J, Hankin EJ, Cunningham SM, Sato AF, Barton BA. Comparison of a computed tomographic pulmonary trunk to aorta diameter ratio with echocardiographic indices of pulmonary hypertension in dogs. Vet Radiol Ultrasound. 2018; 59:(1)18-26 https://doi.org/10.1111/vru.12540

Suzuki S, Fukushima R, Ishikawa T The effect of pimobendan on left atrial pressure in dogs with mitral valve regurgitation. J Vet Intern Med. 2011; 25:(6)1328-1333 https://doi.org/10.1111/j.1939-1676.2011.00800.x

Tilley LP. Essentials of canine and feline electrocardiography: interpretation and treatment, Edition 2. Philadelphia (PA): Lea and Febiger; 1985

Uchide T, Saida K. Elevated endothelin-1 expression in dogs with heartworm disease. J Vet Med Sci. 2005; 67:(11)1155-1161 https://doi.org/10.1292/jvms.67.1155

Ueda Y, Johnson LR, Ontiveros ES Effect of a phosphodiesterase-5A (PDE5A) gene polymorphism on response to sildenafil therapy in canine pulmonary hypertension. Sci Rep. 2019; 9:(1)1-13 https://doi.org/10.1038/s41598-019-43318-z

Venco L, Mihaylova L, Boon JA. Right Pulmonary Artery Distensibility Index (RPAD Index). A field study of an echocardiographic method to detect early development of pulmonary hypertension and its severity even in the absence of regurgitant jets for Doppler evaluation in heartworm-infected dogs. Vet Parasitol. 2014; 206:60-66 https://doi.org/10.1016/j.vetpar.2014.08.016

Vientós-Plotts AI, Wiggen KE, Lisciandro GR The utility of point-of-care ultrasound right-sided cardiac markers as a screening test for moderate to severe pulmonary hypertension in dogs. The Vet J. 2019; 250:6-13 https://doi.org/10.1016/j.tvjl.2019.05.013

Visser LC, Scansen BA, Brown NV Echocardiographic assessment of right ventricular systolic function in conscious healthy dogs following a single dose of pimobendan versus atenolol. J Vet Cardiol. 2015; 17:(3)161-172 https://doi.org/10.1016/j.jvc.2015.04.001

Visser LC, Im MK, Johnson LR Diagnostic value of right pulmonary artery distensibility index in dogs with pulmonary hypertension: comparison with Doppler echocardiographic estimates of pulmonary arterial pressure. J Vet Intern Med. 2016; 30:(2)543-552 https://doi.org/10.1111/jvim.13911

Yang H-J, Oh Y-I, Jeong J-W Comparative single-dose pharmacokinetics of sildenafil after oral and rectal administration in healthy beagle dogs. BMC Vet Res. 2018; 14:(1)1-6 https://doi.org/10.1186/s12917-018-1617-7

Pulmonary hypertension in dogs: an overview

02 April 2021
15 mins read
Volume 26 · Issue 4
Figure 2. Canine, transthoracic, 2-dimensional, right parasternal long-axis view. Visible dilation of right atrium and concentric hypertrophy of the right ventricle, especially the right ventricular free wall (*).
Figure 2. Canine, transthoracic, 2-dimensional, right parasternal long-axis view. Visible dilation of right atrium and concentric hypertrophy of the right ventricle, especially the right ventricular free wall (*).

Abstract

Pulmonary hypertension is a complex syndrome that can be caused by congenital or acquired disease. Congenital conditions include cardiac shunts, such as ventricular septal defect and patent ductus arteriosus. Acquired diseases that eventually lead to pulmonary hypertension include cardiac, systemic and pulmonary pathologies, for example late stage myxomatous mitral valve disease and interstitial lung disease such as idiopathic pulmonary fibrosis. It can be a challenge to identify pulmonary hypertension because the diagnostic process usually requires advanced imaging tools, such as echocardiography, and a good understanding of the animal's history. Pulmonary hypertension can have a profound effect on a dog's quality of life and can lead to severe respiratory distress and damage to the cardiovascular system. Therefore pulmonary hypertension needs to be identified and addressed promptly. Pulmonary hypertension can be reversible in the early stages, but it is generally not reversible when chronic changes to the pulmonary vasculature have occurred. The article reviews the definition of pulmonary hypertension and its pathophysiology, its diagnosis and treatment in canine patients, and discusses the most common congenital and acquired causes.

Pulmonary hypertension is defined as an abnormal increase in pressure within the pulmonary artery. The gold standard method of diagnosing pulmonary hypertension is directly assessing pulmonary arterial pressure (PAP), obtained by right heart catheterisation. According to the human literature, pulmonary hypertension can be diagnosed if mean PAP is ≥25 mmHg at rest (Hoeper et al, 2013). Increased PAP is an abnormal haemodynamic state that can be associated with numerous, diverse disorders which in human patients include diseases such as congenital systemic-to-pulmonary shunts, idiopathic pulmonary fibrosis, chronic thromboembolism or chronic lung disease (Simonneau et al, 2019).

The systemic circulation consists of veins, venules, arteries, arterioles and capillaries, and is a high-pressure system. There is a significant pressure difference between the arterial and venous systems. The inlet is the aorta with high blood pressure of approximately 98–120 mmHg and the outlet is the venae cavae, with pressure of approximately 2–6 mmHg for a typical dog at rest. The pressure difference between the arterial and venous systems is a direct cause of blood flow (Klein et al, 2007).

Register now to continue reading

Thank you for visiting UK-VET Companion Animal and reading some of our peer-reviewed content for veterinary professionals. To continue reading this article, please register today.